{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T20:08:42Z","timestamp":1767125322234,"version":"3.41.2"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>There are three main surgical treatment options for secondary hyperparathyroidism (SHPT): subtotal parathyroidectomy (sPTX), total parathyroidectomy with auto-transplantation (tPTX+AT), and total parathyroidectomy (tPTX). However, a debate regarding which of these surgical methods is optimal has been ongoing. Aim of this study is to compare medical costs and final outcomes associated with the three surgical approaches for the entire treatment duration, aiming to identify the most cost-effective surgical method.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Based on previous research data from domestic and international studies, as well as data from on-site surveys, TreeAge Pro 2022 software was used to construct a Markov model for the surgical treatment of SHPT patients. The model was run using data from the 2022 registered population of end-stage renal disease dialysis patients in China (1 million) as baseline cohort. Main indicators for this analysis are total cost, quality-adjusted life years, and incremental cost-effectiveness ratio (ICER). The study period is 10 years post-surgery, with a discount rate of 5% per year. Uncertainty in the model was assessed using one-way sensitivity analysis and probabilistic sensitivity analysis (PSA).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The costs incurred by SHPT patients undergoing sPTX, tPTX, and tPTX+AT within 10 years post-surgery are $7042.54, $9983.00, and $11435.60, respectively, with total utilities generated being 13.23 QALYs, 18.76 QALYs, and 18.69 QALYs. Compared to sPTX, the incremental costs and incremental effects of tPTX and tPTX+AT are $2,924.71 and $4,456.66, with 5.53 QALYs and 5.46 QALYs, respectively. The ICER for tPTX and tPTX+AT groups are $532.13\/QALY and $805.10\/QALY, respectively, which are well below our set willingness-to-pay (WTP) threshold. Sensitivity analysis results indicate that varying any parameter within a certain range over the given time interval will not cause the ICER to exceed the WTP threshold and will not reverse the primary analysis results.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In the Chinese healthcare system, tPTX is considered the most cost-effective treatment for refractory hyperparathyroidism, when compared to tPTX+AT and sPTX.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2024.1495818","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T06:45:28Z","timestamp":1737960328000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Cost-effectiveness analysis of three surgical approaches for parathyroidectomy in secondary hyperparathyroidism patients"],"prefix":"10.3389","volume":"15","author":[{"given":"Qila","family":"Sa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinghui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangming","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boyuan","family":"Nan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingnan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ningyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wantao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2016.02.024","article-title":"The changing landscape of primary, secondary, and tertiary hyperparathyroidism: highlights from the american college of surgeons panel, \"What's new for the surgeon caring for patients with hyperparathyroidism","volume":"222","author":"Shindo","year":"2016","journal-title":"J Am Coll Surg"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.10370915","article-title":"Rates and outcomes of parathyroidectomy for secondary hyperparathyroidism in the United States","volume":"11","author":"Kim","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfv421","article-title":"Induction of cardiac FGF23\/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease","volume":"31","author":"Leifheit-Nestler","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2018.1467886","article-title":"Prevalence and risk factors for vascular calcification in Chinese patients receiving dialysis: baseline results from a prospective cohort study","volume":"34","author":"Liu","year":"2018","journal-title":"Curr Med Res Opin"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.02110310","article-title":"Cinacalcet effectively reduces parathyroid hormone secretion and gland volume regardless of pretreatment gland size in patients with secondary hyperparathyroidism","volume":"5","author":"Komaba","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1159\/000357951","article-title":"Cinacalcet induces apoptosis in parathyroid cells in patients with secondary hyperparathyroidism: histological and cytological analyses","volume":"124","author":"Tatsumi","year":"2013","journal-title":"Nephron Clin Pract"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.13081211","article-title":"Prescription patterns and mineral metabolism abnormalities in the cinacalcet era: results from the MBD-5D study","volume":"7","author":"Fukagawa","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","article-title":"KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"7","year":"2017","journal-title":"Kidney Int Suppl (2011)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-009-9943-3","article-title":"Surgical and medical treatment of secondary hyperparathyroidism in patients on continuous dialysis","volume":"33","author":"Tominaga","year":"2009","journal-title":"World J Surg"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vhri.2020.07.580","article-title":"Current development and practice of pharmacoeconomic evaluation guidelines for universal health coverage in China","volume":"24","author":"Yue","year":"2021","journal-title":"Value Health Reg Issues"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2017.07.018","article-title":"Subtotal vs. total parathyroidectomy with autotransplantation for patients with renal hyperparathyroidism have similar outcomes","volume":"214","author":"Anderson","year":"2017","journal-title":"Am J Surg"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2017.06.029","article-title":"To assess the effects of parathyroidectomy (TPTX versus TPTX+AT) for Secondary Hyperparathyroidism in chronic renal failure: A Systematic Review and Meta-Analysis","volume":"44","author":"Liu","year":"2017","journal-title":"Int J Surg"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s00423-019-01809-7","article-title":"Subtotal parathyroidectomy versus total parathyroidectomy with autotransplantation for secondary hyperparathyroidism: an updated systematic review and meta-analysis","volume":"404","author":"Yuan","year":"2019","journal-title":"Langenbecks Arch Surg"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000001875","article-title":"Total parathyroidectomy with routine thymectomy and autotransplantation versus total parathyroidectomy alone for secondary hyperparathyroidism: results of a nonconfirmatory multicenter prospective randomized controlled pilot trial","volume":"264","author":"Schlosser","year":"2016","journal-title":"Ann Surg"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2017.1363779","article-title":"Total parathyroidectomy versus total parathyroidectomy with autotransplantation for secondary hyperparathyroidism: systematic review and meta-analysis","volume":"39","author":"Li","year":"2017","journal-title":"Ren Fail"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/nep.2017.22.issue-5","article-title":"Total parathyroidectomy with autotransplantation versus subtotal parathyroidectomy for renal hyperparathyroidism: A systematic review and meta-analysis","volume":"22","author":"Chen","year":"2017","journal-title":"Nephrol (Carlton)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.128.4.389","article-title":"Assessment of the morbidity and complications of total thyroidectomy","volume":"128","author":"Bhattacharyya","year":"2002","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoto.2016.2860","article-title":"A cost-utility analysis of recurrent laryngeal nerve monitoring in the setting of total thyroidectomy","volume":"142","author":"Rocke","year":"2016","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2019.01.019","article-title":"Subtotal parathyroidectomy vs total parathyroidectomy with autotransplantation for secondary hyperparathyroidism in dialysis patients: short- and long-term outcomes","volume":"228","author":"Zmijewski","year":"2019","journal-title":"J Am Coll Surg"},{"key":"B20","doi-asserted-by":"publisher","first-page":"102370","DOI":"10.1016\/j.amjoto.2019.102370","article-title":"Network meta-analysis of surgical treatment for secondary hyperparathyroidism","volume":"41","author":"Hou","year":"2020","journal-title":"Am J Otolaryngol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfg1017","article-title":"Re-operation is frequently required when parathyroid glands remain after initial parathyroidectomy for advanced secondary hyperparathyroidism in uraemic patients","volume":"18","author":"Tominaga","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-200205000-00009","article-title":"Long-term follow-up of patients with tertiary hyperparathyroidism treated by resection of a single or double adenoma","volume":"235","author":"Nichol","year":"2002","journal-title":"Ann Surg"},{"key":"B23","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1038\/ki.2009.188","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","year":"2009","journal-title":"Kidney Int Suppl"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1495818\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T06:45:29Z","timestamp":1737960329000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1495818\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,27]]},"references-count":23,"alternative-id":["10.3389\/fendo.2024.1495818"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2024.1495818","relation":{},"ISSN":["1664-2392"],"issn-type":[{"type":"electronic","value":"1664-2392"}],"subject":[],"published":{"date-parts":[[2025,1,27]]},"article-number":"1495818"}}